Clinical Trial Update: A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry

View source ↗

Summary

A global registry-based study on Hemolytic Disease of the Fetus and Newborn is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemolytic Disease of the Fetus and Newborn

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Hemolytic Disease of the Fetus and Newborn | Status: RECRUITING